FDA — authorised 10 July 1963
- Application: NDA014103
- Marketing authorisation holder: LILLY
- Local brand name: ONCOVIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Oncovin in United States
FDA authorised Oncovin on 10 July 1963
Marketing authorisations
FDA — authorised 16 April 1997
- Application: ANDA071484
- Marketing authorisation holder: HOSPIRA
- Indication: Manufacturing (CMC)
- Status: approved
Oncovin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Oncovin approved in United States?
Yes. FDA authorised it on 10 July 1963; FDA authorised it on 16 April 1997.
Who is the marketing authorisation holder for Oncovin in United States?
LILLY holds the US marketing authorisation.